
Research Projects
AI-Driven Cybersecurityfor Financial Service Providers
CyberAId will significantly enhance the cyber-resilience of European Critical Infrastructures
Política de Privacidade | Política de Cookies
CyberAId will significantly enhance the cyber-resilience of European Critical Infrastructures (CIs) based on the development and deployment of a novel agentic Artificial Intelligence (AI) infrastructure that will be used to intelligently coordinate and orchestrate a pool of state-of-the-art cybersecurity tools and services that address the secure deployment and operation of key digital technologies. The CyberAId infrastructure and tools will leverage cutting edge digital and cybersecurity technologies (i.e. Generative AI, Large Language Models (LLMs), Quantum security) in order to address the entire cyber-resilience lifecycle of financial CI assets and process including incidents and attacks’ prediction, monitoring, reporting and response. At the same time, the agentic AI-based orchestration of CyberAId’s cybersecurity capabilities will enable the project to address common and emerging cybersecurity challenges for European CIs in an integrated, coordinated, scalable and intelligent way that is nowadays hardly possible. In particular, the project will develop, demonstrate, validate and promote the concept of intelligent orchestration of diverse cybersecurity functionalities (e.g., vulnerability assessment, pentesting and cybersecurity simulations, threat correlation, cybersecurity patterns monitoring) as LLM-based “cybersecurity agents”, which will scientifically boost the scalability and the intelligence of cybersecurity for European CIs. The added-value of CyberAId approach stems both from the development of innovative cybersecurity technologies and from their scalable and intelligent orchestration by means of an AI/LLM-based infrastructure.
DIGITAL-ECCC-2024-DEPLOY-CYBER-07-KEYTECH

IHI Project ENKORE:
​
Develop an eco-design framework for single-use medical devices and packaging, reducing environmental impact while ensuring patient safety and regulatory compliance.​
​
FAIRLex's Role:
Advises on ethical, legal, and cultural compliance throughout the project lifecycle, ensuring all eco-design solutions align with FAIR data principles and local regulations.​
Consortium:
Lead by UPM with Medtronic, Pfizer, Johnson & Johnson, Lilly, Nova Nordisk, Salud Madrid, U Leiden. U Lodz, Inbit, ISWA, Technovative Solutions, SteriMed, Activage, UCBM, World Reources Forum, Multimed Engineers, etc.​
​
Impact:
Accelerates sustainable innovation in healthcare by bridging regulatory, technical, and cultural barriers.

Advancing biomarker-driven precision medicine
​
​
IHI Project BRECISE:
Accelerate clinical validation and implementation of NGS-based, AI-driven biomarkers for precision oncology, focusing on prostate and bladder cancer.
​FAIRLex's Role:
Provides expertise on legal and ethical frameworks for biomarker research, data protection, and compliance with European regulations (GDPR, AI Act, Medical Devices Regulation).
​Consortium:
Led by South East Technological University, with Philips, IBIMA, Genomate Health Hungary, Crown Bioscience Netherlands, Hub Organoids, Dedalus Italy, OHMX.Bio Belgium, 3D-PharmXChange, Bioclavis limited, etc.​
Impact:
Enhances personalized cancer care, improves patient outcomes, and ensures regulatory alignment across Europe.
